Direct-to-Patient Survey Results Summary
Health Care, Innovation, Supply Chain
During the 2022 GCSG US conference in San Antonio, 65 attendees participated in our Direct-to-Patient (DtP) survey. While 2/3rd’s of the respondents represented pharmaceutical companies / sponsors, there is also a strong mix of input from service providers. Over 50% of participants also had experience with DtP. Though a need for technology improvements was noted, our industry’s adoption of patient centric services like DTP continues to boost the growth of decentralized trials.
Related Education Resources.
All ResourcesReimagining Clinical Trial Surplus: Harnessing Donations to Close the Global Healthcare Gap
Topics: Supply Chain, Sustainability
White Paper
Free
Current Challenges in Cell and Gene Therapy
Topic: Regulatory
Webinar
Free
Demand Forecasting and the Management of IRT
Topic: Technology
Webinar
Free
